Search results for abx831151

Talquetamab, Abbexa, abx831151

Talquetamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/GPRC5D, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Talquetamab (JNJ-64407564) is a bispecific antibody that targets CD3, which is expressed on T-cells, and GPRC5D, which is highly expressed in multiple myeloma cells. Talquetamab (JNJ-64407564) is being investigated in a Phase 1 clinical study to treat relapsed or refractory multiple myeloma.